# EDGAR Filing Document

**Accession Number:** 0001723464
**File Stem:** 0001723464-25-000029
**Filing Date:** 2025-12
**Character Count:** 10221
**Document Hash:** db8944c7d2bae5563c62e9f71871e3e5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001723464-25-000029.hdr.sgml**: 20251203

**ACCESSION NUMBER**: 0001723464-25-000029

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 4

**CONFORMED PERIOD OF REPORT**: 20251203

**FILED AS OF DATE**: 20251203

**DATE AS OF CHANGE**: 20251203

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BIOHARVEST SCIENCES INC.
- **CENTRAL INDEX KEY:** 0001723464
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42389
- **FILM NUMBER:** 251546018

**BUSINESS ADDRESS:**
- **STREET 1:** 1140 - 625 HOWE STREET
- **CITY:** VANCOUVER
- **STATE:** A1
- **ZIP:** V6C 2T6
- **BUSINESS PHONE:** 6046221186

**MAIL ADDRESS:**
- **STREET 1:** 1140 - 625 HOWE STREET
- **CITY:** VANCOUVER
- **STATE:** A1
- **ZIP:** V6C 2T6

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CANNA-V-CELL SCIENCES INC.
- **DATE OF NAME CHANGE:** 20191008

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Midnight Star Ventures Corp.
- **DATE OF NAME CHANGE:** 20171121

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, DC 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934**

For the month of **December 2025**

Commission file number: **001-42389**

**BIOHARVEST SCIENCES INC.**

(Exact name of Registrant as specified in its charter)

**Not applicable**

(Translation of Registrant's name into English)

**1140-625 Howe Street, Vancouver, British Columbia V6C 2T6, Canada**

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

☐ Form 20-F ☒ Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

------

**SUBMITTED HEREWITH**

**Exhibits:**

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Exhibit** | &nbsp;&nbsp;**Description** |
| &nbsp;&nbsp;[99.1](bhsc_ex991.htm) | &nbsp;&nbsp;News Release dated December 3, 2025 |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
|  | &nbsp;&nbsp;**BIOHARVEST SCIENCES INC.** |
|  | &nbsp;&nbsp;(Registrant) |
| &nbsp;&nbsp;Date: December 3, 2025 | &nbsp;&nbsp;*/s/ David Ryan* |
|  | &nbsp;&nbsp;Name: David Ryan |
|  | &nbsp;&nbsp;Title: Vice-President, Investor Relations & Secretary |

---

## Exhibit 99.1

**BIOHARVEST SCIENCES ANNOUNCES LAUNCH OF VINIA BLOOD FLOW HYDRATION PRODUCT**

**Better Hydration Starts with Better Blood Flow**

![Picture 1](bhscex991_1.jpg)

Example of VINIA Blood Flow Hydration™ packaging, as featured on www.vinia.com

------

polyphenol complex (23mg), including rapid absorption Piceid Resveratrol (6mg), which has been clinically shown to significantly increase arterial dilation, improving blood flow.\*\* Better blood flow ensures more efficient transportation of electrolytes and fluids to our body's organs, muscles, and cells, right where they're needed most.

**A New Era in Blood Flow-Driven Hydration Science**

Dr Suzanne Steinbaum MD, Preventive Cardiologist and Best Selling Author of the "The Heart Health Book: Every Women's Guide to a Heart-Healthy Life", commented "VINIA's Blood Flow Hydration is well named. It is a true 2-in-1 solution because it addresses the problems that are common issues for many people. First, VINIA Blood Flow Hydration increases the dilation of arteries, which improves circulation, and better blood flow is essential to oxygen and nutrient delivery. Second, VINIA Blood Flow Hydration also addresses dehydration, a critical issue for many people, by adding high quality, naturally sourced electrolytes. The combination of water, electrolytes, and VINIA red grape powder's proven ability to improve blood flow with increased dilation enables more efficient delivery of critical fluids and electrolytes to our body's organs, tissues, and cells. That's why I will be recommending VINIA Blood Flow Hydration to my friends and patients."

"My personal experience in leading major brands in the US hydration market while at the Coca-Cola Company have given me the required insights on what is required to drive meaningful differentiation in this multi-billion dollar growing category. I am confident that our strategy of Superior Science, Superior Efficacy and Superior Taste will allow our VINIA Blood Flow Hydration solution to disrupt this market and be a meaningful contributor to driving continued high double-digit revenue growth for the Company." commented Ilan Sobel, CEO of BioHarvest Sciences, adding "No other offering in this rapidly expanding market leverages the power of VINIA's Piceid Resveratrol to address the importance of blood flow in order to drive more effective hydration. Combining the unique, science-based proposition of increased blood flow with a powerful blend of electrolytes derived from nature, we now have 6 great tasting flavors developed by a world class beverage formulator, which gives me the confidence that we can deliver a superior, and Informed Sport Certified, consumer proposition to the market. "

**THE FIRST BLOOD-FLOW-HYDRATION SOLUTION DRIVEN BY VINIA'S PICEID RESVERATROL**

---

| | |
|:---|:---|
| **Six Flavors, Zero Compromise**<br> Developed by a former Coca-Cola flavor formulator, VINIA Blood Flow Hydration™ is available in six light, refreshing flavors: Mixed Berry, Fruit Punch, Watermelon, Summer Orange, Lemonade, and Lemon Lime.<br>**Formulation Highlights** <br> Each stick pack delivers a full daily serving of VINIA®, featuring clinically studied rapid absorption Piceid Resveratrol and naturally sourced electrolytes (470 mg Sodium, 190 mg Potassium, 80 mg Magnesium). The result is a two-in-one formula that hydrates while delivering a steady supply of bioavailable, blood-boosting red-grape polyphenols, representing a major advancement in blood flow driven-hydration science.<br>| ![](bhscex991_2.jpg)  |

---

------

**Third Party Tested & Trusted**

Every batch of VINIA Blood Flow Hydration™ is tested for banned substances under the Informed Sport programme. Products undergo rigorous testing using ISO 17025 accredited methods to provide the highest level of assurance for athletes. For further information about the testing process, please visit informedsport.com.

**90-Day "Feel It or It's Free" Guarantee**

Every order is backed by BioHarvest's 90-Day "Feel It or It's Free" Guarantee, the industry's strongest consumer promise. Customers can use every stick for 90 days. If they do not love the taste or feel the VINIA® difference, VINIA® will refund the full purchase price and cover return shipping. No questions asked.

The company has announced that VINIA Blood Flow Hydration™ is now available to all online consumers for purchase on VINIA.com and will be available on Amazon.com by the end of December. In addition to being available direct-to-consumer via the company's established e-commerce channels, VINIA Blood Flow Hydration™ will also be distributed via select "point-of-sweat" outlets, to service active consumers looking for premium health solutions.

\*Source: https://www.precedenceresearch.com/electrolyte-drinks-market

\*\*Based on BioHarvest sciences clinical trial published in Vaisman et al, 2015, International Journal of Food Sciences and Nutrition. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

------

**About BioHarvest**

BioHarvest (NASDAQ: BHST) (FSE: 8MV) is a leader in Botanical Synthesis, leveraging its patented technology platform to grow plant-based compounds, without the need to grow the underlying plant. BioHarvest is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals; as a contract development and production organization (CDMO) on behalf of customers seeking novel plant-based compounds, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. To learn more, please visit www.bioharvest.com.

**Forward-Looking Statements**

Information set forth in this news release might include forward-looking statements that are based on management's current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Launching new products is subject to risks and uncertainties including the risk that the market will not accept the product or that government approvals required for sale or import of the products will not be obtained. There is never an assurance that any product set will successfully disrupt established product categories, as this depends on factors that may be beyond company control such as consumer preferences, competition landscape, acceptance of benefit claims and marketing budgets of the company and its competitors. All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHST does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures.

**Contacts:**

BioHarvest Corporate Contact:

Dave Ryan, VP Investor Relations

+1 (604) 622-1186

info@bioharvest.com

Investor Relations Contact:

Lucas A. Zimmerman

Managing Director

MZ Group – MZ North America

+1 (949) 259-4987

BHST@mzgroup.us